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t is now apparent that hematopoiesis derives throughout postnatal life from the constant input from a small fraction of hematopoietic stem cells (HSCs) (1, 2) , themselves rare, undergoing cell divisions that include self-renewal to HSCs and differentiation. The differentiation largely to multipotent progenitors (MPPs) that undergo transient amplifying divisions to give rise to all blood cell types but do not undergo long-term selfrenewal (3) . In mice and humans, the steps between HSCs and mature blood cells are stepwise quantal genetic/epigenetic changes with bifurcations to produce progeny with more limited fates; these are the oligopotent and unipotent progenitors, now almost fully described in mouse hematopoiesis (4) . Determining the differentiation pathway leading to erythrocytes and isolating erythroid-specific progenitors are crucial to understanding how fate determinations are made that result in homeostatic production of blood cells and elements. Such an understanding can also elucidate disorders of red cell imbalance, such as anemia, myelodysplastic syndrome (MDS), and polycythemia vera (PV) (5, 6 ). Here we sought to find cell-surface markers that can be used to isolate from human bone marrow each stage of differentiation after the fate determinations that lead MPPs to common myeloid progenitors (CMPs) to megakaryocyte/erythroid progenitors (MEPs) and allow the commitment to erythropoiesis. Certain aspects of erythrocyte development have been elucidated, such as the overall pathway from HSCs through CMPs and MEPs (7) (8) (9) . However, the original human CMP and MEP populations still appear to be heterogeneous, and the subsequent stages of differentiation (i.e., from MEP to erythrocyte) remain unclear.
Given this background, we sought markers that could subdivide CMPs and/or MEPs into cells specifically destined to generate erythrocytes. Erythrocytes, like all blood lineages, develop through a series of differentiation stages that begin with HSCs, which have been prospectively isolated in humans (10) . The surface markers of intermediate erythroid progenitors/precursors and the expression pattern of some pivotal transcription factors (TFs) during their differentiation from HSCs have been analyzed (11) (12) (13) (14) (15) (16) (17) (18) (19) . As a result, the erythroid-committed progenitor (EP), which exists downstream of the bipotent MEP, has been isolated in mouse but not human (9) .
To isolate the presumed human erythrocyte progenitor (hEP), we first looked at markers crucial to isolating the mouse EP. One such key marker is CD105 (endoglin), whereby mouse EPs are Lineage (Lin) − stem cell antigen (Sca)-1 − receptor tyrosine kinase c-Kit
In humans, CD105 and CD71 have been classified as early erythroid cell markers (14) (15) (16) (17) (18) (19) . However, CD105 and CD71 expression in oligopotent myeloid progenitors (8) [i.e., CMPs, granulocyte/macrophage progenitors (GMPs), and MEPs] has not been evaluated. Thus, we examined closely the expression of these markers in CMPs, GMPs, MEPs, and their progeny.
Results

CD71 and CD105 Expression Patterns Subfractionate Myeloid Progenitors.
First, CMPs, GMPs, and MEPs were purified from human bone marrow (BM) according to the flow cytometric sorting scheme shown in Fig. 1A . The BM mononuclear cell fraction that is negative for lineage-affiliated antigens ( + cell fraction of a previously defined megakaryocyte/erythrocyte progenitor population. This purification could be a useful tool for studying physiological and pathological red blood cell development, and should be analyzed in patients suffering from anemia or erythrocytosis such as in myelodysplastic syndrome or polycythemia vera.
We analyzed the expression pattern of putative erythroid markers for each of the progenitor populations. The expression of CD71 was detectable in the CMP (31.5 ± 11.1%, n = 8; Fig.  1A − fraction (14.7 ± 3.4%) (P < 0.0001) (Fig. 2B ). CD71 + CD105 − MEPs generated primarily large E colonies [defined as burst-forming uniterythroid colony (BFU-E)-derived], although they still retained some MegK potential (Fig. 4A) . In contrast, the CD71 int/+ CD105 + MEPs generated only the E lineage, and small-sized colonies from this fraction contained more mature (enucleated) erythrocytes [scored as colony-forming unit-erythroid (CFU-E)-derived] (Fig. 3 C and D 
− as E-biased MEPs (E-MEPs) and the
In contrast, CD71 − CD105 − MEPs frequently generated MegKcontaining colonies but not CFU-GM. Serum-free liquid culture also showed this fraction gave rise most efficiently to CD41 + MegK cells, indicating that these are not just contaminated CD71
− CMPs but might contain putative MegK progenitors.
Immunophenotypic Comparisons Among Subfractionated CMPs/MEPs.
We further characterized the cell-surface markers of the CMP and MEP subfractions. Flt3/flk2 is a tyrosine kinase receptor known for its heterogeneous expression in CMPs, high expression in GMPs, and down-regulation in MegE lineages (23, 24) . Among CMPs, Flt3 − cells are considered to be in a transitional stage to MEPs. In accordance with these earlier findings, our results indicated that Flt3 is expressed on CD71 − CMPs, then gradually down-regulated from CD71 + CMPs to MEPs but highly expressed on GMPs (Fig. S2A) .
Consistent with the in vitro MegK potential, we found that MegK-associated molecules CD41 (13, 25) and CD9 (26) (27) (28) , known to be expressed in the mouse MegK progenitor, were expressed at higher frequencies on the surface of human CD71 (Fig. 4A) . Such phenotypically defined secondary myeloid progenitors displayed differentiation activity consistent with their original phenotypic definition. CD71-expressing cells mainly gave rise to the MegE lineage, and CD105
+ cells almost exclusively produced CFU-E-type erythroid cells.
Suppressive Effect of TGF-β on Proliferation of EPs/E-MEPs Is Accompanied
by Accelerated Terminal Differentiation. We tested the effect of TGF-β1 on MEP subfractions according to the following rationale. CD105 is an accessory molecule of the transforming growth factor beta (TGF-β) type III receptor complex, able to bind TGF-β1 and TGF-β3 but not TGF-β2 (29) . TGF-β, as well as tumor necrosis factor alpha and IFN gamma, is a powerful inhibitor of erythropoiesis both in vivo and in vitro. The suppressive effect of TGF-β on E-lineage cell proliferation is accompanied by an acceleration of terminal maturation (30) (31) (32) (33) (34) .
We found that TGF-β1 did not affect the number of colonies generated by all three MEP subfractions (Fig. 5A ) but affected the types of colonies generated: The proportion of CFU-E-type colonies was increased at the expense of BFU-E-type colonies (Fig. 5 B and C) . By using a serum-free suspension culture, we also monitored the effects of TGF-β1 at an earlier time point. Additional TGF-β1 yielded two-to threefold fewer cells after 4 d of culture (Fig. S4A) , with higher expression levels of GPA (Fig. 5D ) and morphological signs of maturation (Fig. 5E) Gene Expression Analysis of Human Myeloerythroid Progenitors. We previously reported that various TFs play a pivotal role in lineage specification in both mouse (7, 35) and human (8, 36) hematopoiesis. Each purified population described above (CMP and MEP subpopulations and GMPs) was subjected to real-time PCR analysis to test the expression profiles of TFs and lineagerelated cytokine receptor genes (shown in Fig. S5 ). GATA family TFs (GATA-1, GATA-2) and their cofactor Friend of GATA (FOG)-1 are required for MegE lineage development: Knockout of GATA-1 (37, 38) or FOG-1 (39) genes is embryonically lethal in mice due to severe anemia. These GATAs were up-regulated according to MegE lineage differentiation but down-regulated in the GMP stage. On the other hand, GM-affiliated TFs (i.e., C/EBPα, PU.1) were elevated along with GM commitment from CMPs to GMPs but suppressed in MEPs, consistent with previous reports (7, 8) . Erythroid Krüppel-like factor (EKLF; KLF-1) is a critical TF for erythroid development (9, 40, 41) ; KLF-1 and a critical MegK activator, Friend leukemia integration (Fli)-1 (42), antagonize each other at the bifurcation of MegK versus erythroid lineages (40, 43) . Consistent with their hematopoietic outcome, CD71 int/+ CD105 + EPs showed the highest KLF-1 but the lowest Fli-1 expression among the MEP subfractions (Fig. S5) . Conversely, CD71
− CD105 − MEPs showed the lowest KLF-1 but the highest Fli-1 expression among the MEP subfractions, presumably reflecting its robust MegK potential.
EPO signaling is essential for erythroid cell development, especially following the progenitor stage, where EPO mainly blocks apoptosis (44, 45) . We found that EPOR, a gene encoding the EPO receptor, was expressed at divergent levels among subpopulations: low in CMPs, higher in bipotent MegEs, and higher still in CD71 int/+ CD105 + EPs (Fig. S5) . TPO is the most potent cytokine that physiologically regulates MegK and subsequent platelet production (46) . Its receptor (TPOR; c-Mpl) expression was lowest in CD71 int/+ CD105 + EPs among the various MEP subfractions.
These findings suggest that changes in expression patterns of lineage-instructive TFs or lineage-related cytokine receptors in MEPs are similar between human and mouse (9) , although the exact identity of human MegK progenitors remains unclear.
Discussion
We report in the present study that hEPs are prospectively isolatable in adult steady-state bone marrow as a subset of cells among the originally defined hMEPs, showing that the conventional hMEP population is heterogeneous. Moreover, truly bipotent hMEPs reside only in the CD105 − fraction of conventional hMEPs (Fig. 6) .
CD71, the transferrin receptor, has been well-established as one of the early E-lineage markers; the CD34 + CD71 + GPA − fraction, defined as unipotent E-lineage progenitors/precursors, exists at a stage downstream of MEPs, and was used for functional and/or gene expression analysis (11, 13, 30, 47) . However, we found CD71 expression at a much earlier stage of differentiation in a subset of CMPs. A fraction (∼30%) of CMPs is CD71-positive but still retains both GM potential and MegK potential (Fig. 2) . In addition, even CD71 + CD105 − MEPs (E-MEPs) show MegK potential; thus, CD71 alone may be useful for enrichment but is insufficient for the purification of E-lineage progenitors.
Combining CD71 with CD105 (endoglin) staining enables us to identify hEPs. Most colonies that originate from CD71 int/+
CD105
+ hEPs are of the CFU-E type (containing a low number of fully matured erythrocytes; Fig. 3 ), indicating that this isolated fraction corresponds to mouse pre-CFU-Es (9). Importantly, hEPs never generated MegK cells even under serum-free culture conditions, which allow optimal growth and differentiation of MegK progenitors (48) . CD105 is part of the TGF-β receptor complex (29) ; several studies have revealed an inhibitory effect of TGF-β on E-lineage cell proliferation, causing accelerated terminal maturation by blocking the cell cycle of immature cells (30) (31) (32) (33) (34) . However, these studies targeted CD34
+ CD71 + or CD36 + "erythroid progenitors" and not CD105
+ cells. We found a similar effect of TGF-β on the more specific CD71 int/+ CD105 + EPs (Fig. 5) . Therefore, the effect of TGF-β observed in previous studies may be largely due to this subset, because CD71 int/+ CD105 + EPs expressed both CD36 and CD71 on the cell surface (shown in Fig. 1B) . TGF-β is commonly present in FCS and is known to impose negative effects not only on erythroid but also on MegK production (48) . In addition, TGF-β showed a less inhibitory effect on MegK production than that on erythrocyte production (Fig. 5) , and thus it may reflect the absence of CD105 expression in putative MegK progenitors.
We sought to trace the developmental pathway in human CMPs and MEPs in vitro (Fig. 4) . After a 60-h culture, CD71 −
− CMPs could differentiate into CD71 + CD105 − CMPs as well as MEPs/GMPs. CD71 + CD105 − CMPs generated more cells corresponding to E-MEPs and EPs in addition to some CD71 (Fig. 1) ; thus, it could be that CD71 + CD36 + CD105 − cells within the original CMP and/or MEP fractions are earlier committed E progenitors (e.g., pre-BFU-E), although CD36 is reported to be expressed also on MegKs, monocytes (49) , and/or a part of CD13 + CD133 + bipotent myeloerythroid progenitors (50) . Moreover, as shown in Fig. 1B , the expression level of CD36 in CMP subpopulations is quite low, and thus additional cell-surface markers may be required to further investigate this issue. (ii) Is the E-lineage developmental pathway common between fetal and adult hematopoiesis? We found that far fewer EPs existed in cord blood (CB) than in BM (Fig. S1 ). This finding may suggest the immaturity of CB erythroid cells, and could partially explain the delayed recovery of red blood cells and platelets resulting in the increased frequency of blood transfusions frequently seen among patients who received CB transplants compared with allogeneic mobilized peripheral blood stem cell transplants. That being said, both HSC numbers and HSC engraftment potential are other potential contributing variables (51) . CB might possess unknown E-lineage developmental pathways different from adult hematopoiesis. (iii) Are hEPs involved in physiological erythropoiesis in vivo? We have not tested the in vivo lineage potential of isolated hEPs in a xenotransplantation model (52) because of their small numbers and limited proliferation capacity. These subsets of hMEP and hEP populations in patients with unexplained anemia, MDS, or PV will need to be analyzed in comparison with healthy individuals. (iv) How can one isolate MegK lineage-committed progenitors? We found that the expression level of CD41, a well-established marker for MegK progenitors both in mouse (9) and human (13, 25) , was up-regulated with MegE differentiation and downregulated in CD105 + EPs (Fig. S2 B and C) . To isolate MegKcommitted progenitors at the CMP or MEP level, a marker other than or in addition to CD41 is necessary. Recently, MegK-biased HSCs (53) and MegK-committed progenitors with long-term repopulating capacity (54) within the mouse HSC compartment have been reported. In humans as well, a portion of MegK progenitors might develop directly from earlier stem cells/progenitors such as HSCs and MPPs, bypassing the CMP or MEP stage.
Although the MegK developmental pathway remains undetermined, the use of key TFs, at least in the E lineage, appears to be well-preserved between human and mouse (Fig. S5) All sorting and analyses were performed on a three laser-equipped FACSAria II (BD Biosciences). The automatic cell-deposition system was used for single-cell assays. FACS data were analyzed with FlowJo software (Tree Star).
Cell Culture. All cultures were incubated in a humidified chamber in 5% CO 2 . Colonies were scored and picked up for making cytospin preparations to define cell components.
Gene Expression Analysis. Total RNA was extracted from purified progenitor populations using TRIzol reagent (Life Technologies) according to the manufacturer's protocol. All RNA samples were reverse-transcribed with Oligo(dT) primers using the SuperScript III First-Strand Synthesis System (Invitrogen/Life Technologies). Quantitative real-time PCR assays were performed with the 7900HT Fast Real-Time PCR System (Life Technologies). All specific primers and probes were purchased from inventoried stocks of TaqMan Gene Expression Assays (Applied Biosystems/Life Technologies). GAPDH transcripts were simultaneously amplified as an internal standard for quantification. All samples were analyzed in triplicate.
Statistical Analysis. The unpaired two-tailed Student t test was applied to all pairwise comparisons of mean values after F-test evaluation of variance. All statistical analyses were performed with Prism 5 software (GraphPad).
